Navigation Links
Bisexuality not a transitional phase among women, according to new research
Date:1/15/2008

-- but more than half of these women switched back to bisexual or unlabeled by the end.

  • By year 10, most of the women were involved in long-term (i.e., more than a year in length) monogamous relationships -- 70 percent of the self-identified lesbians, 89 percent of the bisexuals, 85 percent of the unlabeled women and 67 percent of those who were then calling themselves heterosexual.

  • Women's definitions of lesbianism appeared to permit more flexibility in behavior than their definitions of heterosexuality. For example, of the women who identified as lesbian in the last round of interviews, 15 percent reported having sexual contact with a man during the prior two years. In contrast, none of the women who settled on a heterosexual label at that point reported having sexual contact with a woman within the previous two years.

"This provides further support for the notion that female sexuality is relatively fluid and that the distinction between lesbian and bisexual women is not a rigid one," Diamond wrote.


'/>"/>

Contact: Pam Willenz
pwillenz@apa.org
202-336-5707
American Psychological Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Seabrook House Opens Transitional Living Facility: Seabrook West
2. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
3. Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma
4. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
5. Cytopia Commences Phase II Cancer Drug Study
6. QRxPharma Initiates Second Phase III Clinical Trial for its Dual Opioid Pain Therapy
7. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
8. Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
9. Early Phase II results show bosutinib safe, effective for CML
10. CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
11. VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... ... review 2015” provides comprehensive information on the pipeline products with comparative analysis ... pressure wound therapy (NPWT) with 22 market data tables and 4 figures, ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder of New ... a leading international authority on the conservative treatment of back, hip, knee and ...
(Date:7/2/2015)... OR (PRWEB) , ... July 02, 2015 , ... Hand ... During the current summer flu season, according to fresh water advocate and radio host ... on the hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied ...
(Date:7/2/2015)... ... July 02, 2015 , ... The report ... Capsule manufacturers. The report is a valuable source of guidance and direction for ... and Chinese market for the Gelatin Capsule industry including capacity, production, production value, ...
(Date:7/2/2015)... ... July 02, 2015 , ... As the world becomes more connected through the ... interact with products in their everyday lives. Technology can now help homeowners gain more ... entertainment and safety, as well as making kitchen tasks simpler. , "Summer ...
Breaking Medicine News(10 mins):Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4
... has affected poultry in Burhanpur district of Madhya Pradesh, which is ... in 14 villages of Jalgaon have already been tested positive for ... matter of time that these strains will be identified as H5N1 ... previous one. ,The Maharashtra government has promised financial assistance ...
... number of babies born in the house. Office of National ... 2004. The group BirthChoiceUK.com said Merseyside and Northumbria had the ... The National Childbirth Trust said that women could not have ... to opt for a home birth if they are likely ...
... Vagisil Women's Health CenterSM conducted a survey on feminine hygiene. ... are taking active roles in their own feminine health and ... 18 and older (63 percent) report that they go to ... 61 percent say they "always" go for their annual exams. ...
... African-Americans is almost twice as high as that found ... been searching for an explanation for this difference. Now ... this racial difference exists. ,"Pulmonary fibrosis is ... sacs are replaced by tough fibrotic tissue," Galina Bogatkevich ...
... with AIDS in the early 1990's when she was 35, ... earlier// of AIDS related complications, had infected her. Smith also ... live. , One day, flipping through a magazine ... buy her $150,000 life insurance policy. Smith had no children ...
... Hubbard, a close friend of President Bush, a ... president's health care proposals, he has found the solution for ... provide bigger tax breaks for health savings accounts ... and ... ,Hubbard seeks to get the people to think about what ...
Cached Medicine News:Health News:Women aware of “feminine health” : their attitud 2Health News:Malfunction Of Key Growth Factor Increases Mortality Rate From Pulmonary Fibrosis In Blacks 2
(Date:7/2/2015)... ROCKY HILL, Conn. , July 2, 2015 /PRNewswire/ ... , Chief Executive Officer announced that Tamas Feitel ... Feitel joins Numotion after a highly successful ... global finance leadership roles driving strategy, profitability, and productivity ... generation. His most recent position was Chief Financial Officer ...
(Date:7/2/2015)... , July 2, 2015 ... (Homofermentative & Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes ... and Forecast to 2020", Silage Inoculants & Enzymes Market ... a CAGR of 4.0% from 2015 to 2020. ... igures spread through 194 P ...
(Date:7/2/2015)... , 2 de julio de 2015 ... ADN de alto rendimiento en ... American College of Pathologists (CAP). La instalación de BGI en ... laboratorio de secuenciación de próxima generación que recibe la ... el más alto estándar en prácticas de laboratorio clínico. ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI recibe la acreditación del College of American Pathologists (CAP) 2
... and NEW YORK, Feb. 24, 2012   ACCESS PHARMACEUTICALS, ... its proprietary drug-delivery platforms to develop treatments in areas ... its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., ... in China from the State Food and Drug Administration, ...
... Pharmaceuticals (Nasdaq: ENDP ) today reported financial results ... during the fourth quarter of 2011 increased 57 percent to ... of 2010.  Net income for the three months ended Dec. ... the comparable 2010 period.   Additionally, adjusted net ...
Cached Medicine Technology:Access Pharmaceuticals Receives Final Marketing Approval From SFDA of China for MuGard 2Access Pharmaceuticals Receives Final Marketing Approval From SFDA of China for MuGard 3Access Pharmaceuticals Receives Final Marketing Approval From SFDA of China for MuGard 4Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 2Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 3Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 4Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 5Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 6Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 7Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 8Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 9Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 10Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 11Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 12Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 13Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 14Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 15Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 16Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 17Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance 18
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca...
An easy-to-fit RGP daily wear lens with a unique bi-aspheric back surface design that provides excellent patient comfort and adaptation. Boston Envision contact lenses are an ideal alternative for vi...
Hydraulic ophthalmic stretcher for eye surgery....
... ingredient indocyanine green-ICG) is a diagnostic dye ... volume diagnosis, and liver function diagnosis. Aurogreen ... minor side - effect like iodide allergy ... safer than fluorescein sodium. Vomiting and nausea ...
Medicine Products: